Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Contemporary Update of Overall Prognosis and Nomogram to Predict Individualized Survival for Chinese Patients with Eyelid Sebaceous Carcinoma
32 Pages Posted: 23 Jan 2019
More...Abstract
Background: The prognosis of Chinese patients with eyelid sebaceous gland carcinoma (SC) has not been updated for more than 3 decades. The predictors for the prognoses are multifactorial, there is no validated prognostic model for eyelid SC.
Methods: The study included 238 consecutive patients with eyelid SC. All patients were followed up for metastasis and mortality. The predictors of tumor-related survival were explored by Cox analyses. A prognostic nomogram was developed and validated using bootstrap resampling. The predictive accuracy and discriminative ability were compared between nomogram and Tumor, Node, Metastasis (TNM) staging system.
Findings: After a median follow-up period of 55.5 months, 27 (11.3%) patients died of the metastatic SC, with a median survival time of 48.0 months. The 5-year and 10-year tumor-related survival rate was 88.1% and 77.9%, respectively. Prior radiation therapy (HR:5.63, p=0.003), tumor with orbital involvement (HR:4.64, p=0.001), greatest tumor basal diameter (HR:1.07, p<0.001), the presence of pagetoid spread (HR:3.12, p=0.012) were the independent risk factors for tumor-related death. Nomogram integrating these 4 factors was developed with a C-index of 0.875, which is significantly better than that of TNM staging system (p=0.038). The risk groups stratified by nomogram scores (p=0.042 (low vs intermediate risk); p<0.001 (intermediate vs high risk)) displayed better discrimination ability than TNM staging (T1vsT2: p=0.358; T2vsT3: p=0.171; T3vsT4: p<0.001) in patients at an early stage.
Interpretation: The prognosis of Chinese patients of eyelid SC has been improved for the last 3 decades, and it is comparable to the patients from other countries. This nomogram provides more-accurate individualized estimates of survival for eyelid SC patients, and may guide clinicians in their therapeutic decisions.
Funding Statement: This work was supported by the Scientific Research Program of the National Health and Family Planning Commission of China (201402014).
Declaration of Interests: The authors declare no conflict of interest in this paper.
Ethics Approval Statement: This study adhered to the tenets of the Declaration of Helsinki and was approved by the Shanghai Jiaotong University research ethics committee.
Keywords: eyelid sebaceous carcinoma; nomogram; tumor-related survival
Suggested Citation: Suggested Citation